- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05491772
Multicentric Retrospective Study of Perinatal Mortality (PM-PHD-NTM)
August 5, 2022 updated by: Nuria Torre-Monmany, Corporacion Parc Tauli
Clasificación y Factores de Riesgo de la Mortalidad Perinatatal
Background: Perinatal mortality ranges mortality from 22 gestational weeks up to the first 7 days of life and extended mortality goes up to 28 days of life.
The perinatal mortality rate is the most sensitive index of the health status of women and their offspring and of the quality of maternal and child health services.
Per our knowledge, there is no study that evaluates perinatal mortality in Catalonia, although household data are available from each hospital.
Moreover, the official records usually do not match with the household surveys due to lack of clarity on the definitions.
Aim: the aim of the study is to compare the WHO perinatal mortality classification following the ICD-PM in comparison with the used classification.
Methodology: Multicentric retrospective study.
Data from Sant Joan de Déu, Maternitat Clinic and Parc Taulí hospitals.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
468
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nuria Torre, MD
- Phone Number: 29312 937231010
- Email: ntorre@tauli.cat
Study Locations
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08208
- Recruiting
- CorporacionPT
-
Contact:
- Nuria Torre, MD
- Phone Number: 937231010
- Email: ntorre@tauli.cat
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 4 weeks (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Perinatal
Description
Inclusion Criteria:
- stillbirths more than 22 weeks of gestation
- neonatal deaths up to 28 days of life
Exclusion Criteria:
- avortions more than 22 weeks of gestation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Classification of Disease (10th Revision)- Perinatal Mortalitymaternal condition group
Time Frame: through study completion, an average of 1 year
|
The ICD-PM provides a standardised system for classifying perinatal mortality (including stillbirths) based on time of death (antepartum or intrapartum) into fetal and maternal causes thereby enabling comparisons within and between diverse settings and contexts
|
through study completion, an average of 1 year
|
International Classification of Disease (10th Revision)- Perinatal Mortality cause of death
Time Frame: through study completion, an average of 1 year
|
The ICD-PM provides a standardised system for classifying perinatal mortality (including stillbirths) based on time of death (antepartum or intrapartum) into fetal and maternal causes thereby enabling comparisons within and between diverse settings and contexts
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Obstetric history
Time Frame: through study completion, an average of 1 year
|
number of pregnancies, number of total live births, number of deceased babies, number of stillbirths, number of neonatal deaths, number of abortions
|
through study completion, an average of 1 year
|
Mother's age
Time Frame: through study completion, an average of 1 year
|
age
|
through study completion, an average of 1 year
|
Type of pregnancy
Time Frame: through study completion, an average of 1 year
|
singleton, twins
|
through study completion, an average of 1 year
|
Antenatal care number of visits
Time Frame: through study completion, an average of 1 year
|
number
|
through study completion, an average of 1 year
|
Malaria profilaxis
Time Frame: through study completion, an average of 1 year
|
yes, no
|
through study completion, an average of 1 year
|
HIV status
Time Frame: through study completion, an average of 1 year
|
positive, negative
|
through study completion, an average of 1 year
|
Syphilis test
Time Frame: through study completion, an average of 1 year
|
positive, negative
|
through study completion, an average of 1 year
|
Mother's LMP
Time Frame: through study completion, an average of 1 year
|
date of the last menstrual period
|
through study completion, an average of 1 year
|
Date of birth
Time Frame: through study completion, an average of 1 year
|
date
|
through study completion, an average of 1 year
|
Gestational age
Time Frame: through study completion, an average of 1 year
|
weeks
|
through study completion, an average of 1 year
|
Place of delivery
Time Frame: through study completion, an average of 1 year
|
facility, home, road, others
|
through study completion, an average of 1 year
|
Onset of labour
Time Frame: through study completion, an average of 1 year
|
spontaneous, induced, cesarean before onset
|
through study completion, an average of 1 year
|
Fetal heart sounds on admission
Time Frame: through study completion, an average of 1 year
|
yes, no
|
through study completion, an average of 1 year
|
Partograph used
Time Frame: through study completion, an average of 1 year
|
yes, no
|
through study completion, an average of 1 year
|
Mode of delivery
Time Frame: through study completion, an average of 1 year
|
vaginal, vaginal assisted, cesarean
|
through study completion, an average of 1 year
|
Time between decision for action and birth
Time Frame: through study completion, an average of 1 year
|
not applicable, < 30 min, 30 - 60 min, > 60 min
|
through study completion, an average of 1 year
|
Apgar Score
Time Frame: through study completion, an average of 1 year
|
Apgar Score (min 0, max 10).
Higher scores means better outcome
|
through study completion, an average of 1 year
|
Resuscitation
Time Frame: through study completion, an average of 1 year
|
not necessary, suction, stimulation, ventilation, cardiac compressions, not done
|
through study completion, an average of 1 year
|
Sex of baby
Time Frame: through study completion, an average of 1 year
|
male, female, unknown
|
through study completion, an average of 1 year
|
Birth weight
Time Frame: through study completion, an average of 1 year
|
grams
|
through study completion, an average of 1 year
|
Date of death
Time Frame: through study completion, an average of 1 year
|
Date
|
through study completion, an average of 1 year
|
Type of death
Time Frame: through study completion, an average of 1 year
|
neonatal, intrapartum or antepartum or unknown timing stillbirth
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 5, 2022
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
July 24, 2022
First Submitted That Met QC Criteria
August 5, 2022
First Posted (Actual)
August 8, 2022
Study Record Updates
Last Update Posted (Actual)
August 8, 2022
Last Update Submitted That Met QC Criteria
August 5, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Perinatal mortality - pHD NTM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stillbirth
-
Hawler Medical UniversityCompletedUnexplained StillbirthIraq
-
Centre Hospitalier Universitaire de NīmesCompletedCaesarean Section;Stillbirth
-
Università degli Studi dell'InsubriaNot yet recruitingPregnancy Complications | Delivery;Abnormal;Stillbirth
-
Hacettepe UniversityRecruitingPain | Breastfeeding | Caesarean Section;StillbirthTurkey
-
Centre Hospitalier Universitaire de BesanconCompletedTermination of Pregnancy | Neonatal Death | Stillbirth and Fetal DeathFrance
-
Policlinico HospitalUnknownMicrobial Colonization | Caesarean Section;StillbirthItaly
-
NICHD Global Network for Women's and Children's...CompletedMaternal Morbidity and Mortality | Stillbirth and Neonatal MortalityZambia, India, Pakistan, Kenya, Guatemala, Argentina
-
University of ManchesterUniversity of Leeds; University of Birmingham; University of LeicesterRecruitingPerinatal Death | Stillbirth and Fetal DeathUnited Kingdom
-
Cukurova UniversityEnrolling by invitationCaesarean Section;Stillbirth | Postpartum ComplicationTurkey
-
Balikesir UniversityCompletedDelivery;Breech;StillbirthTurkey